HPV Vaccine Help Reduces Risk of Cervical Cancer

Oct, 2020 - By SMI

Gardasil 9 is an HPV vaccine approved by the United States Food and Drug Administration (FDA) and can be used for both girls and boys.

According to the new analysis of Danish health registry data, the human papillomavirus (HPV) vaccine help reduce the risk of a condition that leads to cervical cancer. The research was published in the Acta obstetricia et Gynecologicia Scandinavica journal. HPV is a viral infection that is passed between people through skin-to-skin contact. There are more than 100 varieties of HPV, of which over 40 undergo sexual contact and can affect the throat, mouth, or genitals of a human being. Cervical cancer occurs in the cells of the cervix, tissue that connects the uterus and vagina.

Various strains of HPV plays an important role in causing most cervical cancer. During this research, the researchers examined two groups of women, those who born in 1983 and 1993. The team offered free HPV vaccination to those who born in 1993, at the age of 15 years. However, the researchers did not offer free HPV vaccination to those who born in 1983. Participants were followed from age 15 to 25 years. The team found around 91% vaccination coverage in those who born in 1993 and 0.1% vaccination coverage in those who born in 1983.

A precancerous condition named high grade cervical intraepithelial neoplasia was found in 3% of the 19,951 women in the 1993 birth group and 4% of the 15,748 women in the 1983 birth group. Moreover, the researchers found that the risk of high-grade cervical intraepithelial neoplasia has been reduced by around 30% in those who born in 1993 compared to those who born in 1983. Gardasil 9 is an HPV vaccine approved by the United States Food and Drug Administration (FDA) and can be used for both girls and boys. Gardasil 9 can prevent the majority of cervical cancer cases if given before a woman or girl is exposed to the virus.